Playback speed
10 seconds
Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecific Antibody Targeting EGFR and LGR5, in Advanced HNSCC
By
AACR 2023 Conference Coverage
FEATURING
Ezra Cohen
By
AACR 2023 Conference Coverage
FEATURING
Ezra Cohen
206 views
May 18, 2023
Comments 0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY